Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-09-26FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc., resulting in updated labeling for the product.
-
EMA safety_alert · 2011-09-22European Medicines Agency recommends restricting use of Multaq
The EMA recommends restricting the use of Multaq (dronedarone) due to safety concerns and safer alternatives; explicit usage restrictions an…
-
CLINICAL_TRIALS trial_result · 2011-09-20Clinical Trial Update: Data Collection and Analysis of Patients Who Have Had an Electrophysiological Procedure
This clinical trial update describes data collection and analysis for patients who have undergone an electrophysiological procedure. The stu…
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation [Phase 2]
Phase 2 trial comparing Cartomerge versus NavX Fusion for catheter ablation in atrial fibrillation has completed; the provided information d…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study [NA]
This update reports on a TIARA pilot study using transesophageal echocardiography to identify atrial fibrillation patients at low risk of st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-08-22FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for MULTAQ (dronedarone) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2011-08-19FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
FDA approved Oceanside Pharmaceuticals' supplemental application for diltiazem hydrochloride, allowing continued marketing of this generic p…
-
FDA approval · 2011-08-17FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) from Legacy Pharma USA, Inc.
-
CLINICAL_TRIALS research · 2011-08-12Clinical Trial Update: Ongoing WARfarin and Coronary STENTing
This document is an update on an ongoing clinical trial evaluating warfarin in conjunction with coronary stenting for patients with acute co…
-
CLINICAL_TRIALS research · 2011-08-08Clinical Trial Update: Catheter Ablation Versus Medical Treatment of AF in Heart Failure [NA]
This entry notes a clinical trial comparing catheter ablation versus medical treatment for atrial fibrillation in patients with heart failur…
-
FDA approval · 2011-08-03FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved verapamil hydrochloride as an original application generic drug by Glenmark; the product is indicated for conditions treated by…
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Characterisation of Fractionated Electrograms Critical for Maintenance of Atrial Fibrillation (AF) [NA]
Completed clinical trial from Barts & The London NHS Trust investigating the characterization of fractionated electrograms critical for main…
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) [Phase 2]
A Phase 2 trial update for persistent or permanent non-valvular atrial fibrillation in patients not taking vitamin K antagonists; the study …
-
CLINICAL_TRIALS research · 2011-07-26Clinical Trial Update: Low Dose of Diltiazem for Rate Control of Atrial Fibrillation [Phase 4]
Phase 4 clinical trial evaluating low-dose diltiazem for rate control in atrial fibrillation; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure
This completed clinical trial at Samsung Medical Center evaluated whether a biochemical marker could predict recurrence of atrial fibrillati…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Simple Warfarin Dosing Algorithm Study [NA]
Completed clinical trial evaluating a simple dosing algorithm for warfarin to optimize anticoagulation dosing.
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation [Phase 3]
A Phase 3 trial evaluating n-3 polyunsaturated fatty acids for the prevention of atrial fibrillation has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Visualization and Structured Attention Behaviour for Pain and Anxiety Reduction During Ablation of Atrial Fibrillation [NA]
This update summarizes a completed trial evaluating visualization and structured attention techniques to reduce pain and anxiety during atri…
-
CLINICAL_TRIALS other · 2011-07-20Clinical Trial Update: Implanted Loop Recorder Post Atrial Fibrillation Ablation
This clinical trial update concerns the use of an implanted loop recorder in patients who have undergone atrial fibrillation ablation.
-
FDA approval · 2011-07-11FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for propafenone hydrochloride, enabling its generic marketing by Strides Pharma Science Limited as a…
-
FDA approval · 2011-07-11FDA Approved: TIKOSYN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TIKOSYN (dofetilide) from Pfizer Laboratories Div Pfizer Inc.
-
EMA safety_alert · 2011-07-11European Medicines Agency reviews cardiovascular risk of Multaq
The European Medicines Agency is reviewing cardiovascular risk associated with Multaq (dronedarone) to assess safety in patients with atrial…
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace [NA]
This clinical trial update reports termination of an IDE study evaluating closed-loop stimulation and cardiac resynchronization pacing for a…
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
This clinical trial update investigates whether a reduced dose of enoxaparin affects outcomes in patients receiving enoxaparin therapy. The …
-
CLINICAL_TRIALS research · 2011-06-30Clinical Trial Update: Catheter Versus Thoracoscopic Surgical Ablation Strategy in Persistent Atrial Fibrillation [NA]
This clinical trial update compares catheter-based ablation with thoracoscopic surgical ablation for persistent atrial fibrillation; the cur…